Association of New York Heart Association functional class IV symptoms at admission and clinical features with outcomes in patients hospitalized for acute heart failure syndromes

被引:11
作者
Asano, Ryotaro [1 ]
Kajimoto, Katsuya [2 ]
Oka, Toshiaki [1 ]
Sugiura, Ryo [1 ]
Okada, Hisayuki [1 ]
Kamishima, Kazuho [1 ]
Hirata, Tetsuo [1 ]
Sato, Naoki [3 ]
机构
[1] Seirei Hamamatsu Gen Hosp, Dept Cardiol, Shizuoka, Japan
[2] Sekikawa Hosp, Div Cardiol, Tokyo, Japan
[3] Musashi Kosugi Hosp, Nippon Med Sch, Internal Med Cardiol & Intens Care Unit, Kawasaki, Kanagawa, Japan
关键词
Acute heart failure syndromes; New York Heart Association functional class; In-hospital outcome; Assessment; PRESERVED SYSTOLIC FUNCTION; EJECTION FRACTION; RISK STRATIFICATION; NATURAL-HISTORY; OPTIMIZE-HF; MORTALITY; MANAGEMENT; REGISTRY; CLASSIFICATION; PREDICTORS;
D O I
10.1016/j.ijcard.2016.12.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It remains unclear whether there are subgroups of acute heart failure syndromes (AHFS) patients in whom New York Heart Association (NYHA) class IV symptoms at admission is related to a higher risk of mortality because of the heterogeneity of this patient population. The aim of this study was to evaluate the association of NYHA class IV symptoms at baseline with in-hospital mortality in subgroups of patients with AHFS. Methods and Results: Of the 4842 patients enrolled in the Acute Decompensated Heart Failure Syndromes (ATTEND) registry, 4786 patients were included in this analysis. The primary endpoint was in-hospital all-cause death. NYHA class IV at baseline was detected in 44.3% of the patients. The all-cause death rate was significantly higher in patients with NYHA class IV than in those with NYHA class II or III (9.0% vs. 4.3%, P < 0.001). To examine the heterogeneity of the association between NYHA class IV symptoms at baseline and in-hospitalmortality, subgroup analyses were performed. As a result, the presence of NYHA class IV symptoms on admission was associated with a significantly higher risk of all-cause death in patients aged >= 75 years, female patients, patients without an idiopathic dilated etiology, and patients with preserved ejection fraction (EF). Conclusions: This study demonstrated that an age >= 75 years, female gender, the absence of idiopathic dilated etiology, and a preserved EF should be considered when assessing the clinical significance of NYHA class IV symptoms in relation to the risk of in-hospital mortality in patients hospitalized for AHFS. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:585 / 591
页数:7
相关论文
共 36 条
  • [1] Predictors of in-hospital mortality in patients hospitalized for heart failure - Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
    Abraham, William T.
    Fonarow, Gregg C.
    Albert, Nancy M.
    Stough, Wendy Gattis
    Gheorghiade, Mihai
    Greenberg, Barry H.
    O'Connor, Christopher M.
    Sun, Jie Lena
    Yancy, Clyde W.
    Young, James B.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (05) : 347 - 356
  • [2] Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function
    Ahmed, A
    Aronow, WS
    Fleg, JL
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (02) : 444 - 450
  • [3] A propensity-matched study of the association of physical function and outcomes in geriatric heart failure
    Ahmed, Ali
    Aronow, Wilbert S.
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2008, 46 (02) : 161 - 172
  • [5] The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries
    Ambrosy, Andrew P.
    Fonarow, Gregg C.
    Butler, Javed
    Chioncel, Ovidiu
    Greene, Stephen J.
    Vaduganathan, Muthiah
    Nodari, Savina
    Lam, Carolyn S. P.
    Sato, Naoki
    Shah, Ami N.
    Gheorghiade, Mihai
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : 1123 - 1133
  • [6] [Anonymous], 1994, Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, P253
  • [7] Anselmino M., 2009, PACING CLIN ELECTROP, V32, P214
  • [8] Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease
    Bennett, JA
    Riegel, B
    Bittner, V
    Nichols, J
    [J]. HEART & LUNG, 2002, 31 (04): : 262 - 270
  • [9] Beth A., 2016, EUR J HEART FAIL, V18, P1041
  • [10] Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program
    Blair, John E. A.
    Zannad, Faiez
    Konstam, Marvin A.
    Cook, Thomas
    Traver, Brian
    Burnett, John C., Jr.
    Grinfeld, Liliana
    Krasa, Holly
    Maggioni, Aldo P.
    Orlandi, Cesare
    Swedberg, Karl
    Udelson, James E.
    Zimmer, Christopher
    Gheorghiade, Mihai
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (20) : 1640 - 1648